Genetics of coronary artery disease in the post-GWAS era
- PMID: 34237186
- DOI: 10.1111/joim.13362
Genetics of coronary artery disease in the post-GWAS era
Abstract
During the past decade, genome-wide association studies (GWAS) have transformed our understanding of many heritable traits. Three recent large-scale GWAS meta-analyses now further markedly expand the knowledge on coronary artery disease (CAD) genetics in doubling the number of loci with genome-wide significant signals. Here, we review the unprecedented discoveries of CAD GWAS on low-frequency variants, underrepresented populations, sex differences and integrated polygenic risk. We present the milestones of CAD GWAS and post-GWAS studies from 2007 to 2021, and the trend in identification of variants with smaller odds ratio by year due to the increasing sample size. We compile the 321 CAD loci discovered thus far and classify candidate genes as well as distinct functional pathways on the road to indepth biological investigation and identification of novel treatment targets. We draw attention to systems genetics in integrating these loci into gene regulatory networks within and across tissues. We review the traits, biomarkers and diseases scrutinized by Mendelian randomization studies for CAD. Finally, we discuss the potentials and concerns of polygenic scores in predicting CAD risk in patient care as well as future directions of GWAS and post-GWAS studies in the field of precision medicine.
Keywords: Mendelian randomization; coronary artery disease; genome-wide association study; polygenic risk score; precision medicine; systems genetics.
© 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
Similar articles
-
GWAS breakthroughs: mapping the journey from one locus to 393 significant coronary artery disease associations.Cardiovasc Res. 2024 Nov 5;120(13):1508-1530. doi: 10.1093/cvr/cvae161. Cardiovasc Res. 2024. PMID: 39073758 Review.
-
Candidate pathway-based genome-wide association studies identify novel associations of genomic variants in the complement system associated with coronary artery disease.Circ Cardiovasc Genet. 2014 Dec;7(6):887-94. doi: 10.1161/CIRCGENETICS.114.000738. Epub 2014 Sep 23. Circ Cardiovasc Genet. 2014. PMID: 25249547 Free PMC article.
-
Identification of susceptibility modules for coronary artery disease using a genome wide integrated network analysis.Gene. 2013 Dec 1;531(2):347-54. doi: 10.1016/j.gene.2013.08.059. Epub 2013 Aug 29. Gene. 2013. PMID: 23994195
-
Genetics of Coronary Artery Disease.Circ Res. 2016 Feb 19;118(4):564-78. doi: 10.1161/CIRCRESAHA.115.306566. Circ Res. 2016. PMID: 26892958 Review.
-
Genome-Wide Association Studies of Coronary Artery Disease: Recent Progress and Challenges Ahead.Curr Atheroscler Rep. 2018 Jul 18;20(9):47. doi: 10.1007/s11883-018-0748-4. Curr Atheroscler Rep. 2018. PMID: 30022313 Review.
Cited by
-
Marital status and genetic liability independently predict coronary heart disease incidence.Scand J Public Health. 2024 Feb;52(1):1-4. doi: 10.1177/14034948221119634. Epub 2022 Sep 7. Scand J Public Health. 2024. PMID: 36071625 Free PMC article.
-
Risk Prediction of Cardiovascular Events by Exploration of Molecular Data with Explainable Artificial Intelligence.Int J Mol Sci. 2021 Sep 24;22(19):10291. doi: 10.3390/ijms221910291. Int J Mol Sci. 2021. PMID: 34638627 Free PMC article. Review.
-
Exploring the role of Sirtuin 3 gene polymorphisms and oxidative stress markers in the susceptibility to coronary artery disease.Mol Biol Rep. 2023 Nov;50(11):9221-9228. doi: 10.1007/s11033-023-08825-3. Epub 2023 Oct 6. Mol Biol Rep. 2023. PMID: 37801276
-
An updated analysis on the association of GSTM1 polymorphism and smoking exposure with the increased risk of coronary heart disease.J Int Med Res. 2022 Sep;50(9):3000605221123697. doi: 10.1177/03000605221123697. J Int Med Res. 2022. PMID: 36112810 Free PMC article.
-
Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome.Diagnostics (Basel). 2023 Jul 12;13(14):2348. doi: 10.3390/diagnostics13142348. Diagnostics (Basel). 2023. PMID: 37510094 Free PMC article. Review.
References
-
- Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982-3021.
-
- Erdmann J, Kessler T, Munoz Venegas L, Schunkert H. A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc Res. 2018;114(9):1241-57.
-
- Koyama S, Ito K, Terao C, Akiyama M, Horikoshi M, Momozawa Y, et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. Nat Genet. 2020;52(11):1169-77.
-
- Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357(5):443-53.
-
- Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316(5830):1491-3.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous